mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.9 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |